US Drug Recall Register
Class I · High risk Terminated Initiated Feb 18, 2021 (6 years ago)

Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous…

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Crystallization: customer complaints for crystallization in finished product.

What was recalled

Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 20mL Single-Dose Vials per pack NDC 68382-049-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India. Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.

Recalling firm
Zydus Pharmaceuticals (USA) Inc
NDC code
68382-049-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0315-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Acyclovir recalls

See all